IMU Biosciences' precision medicine platform maps the immune system to improve diagnosis, treatment, and healthcare outcomes.

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...

Doctors are looking to recruit more people for the trial, which they say could one day be given as a single one-off treatment ...

Working with an international team of collaborators, scientists at Columbia University have found a way to shift the balance ...

Cedars-Sinai researchers created “young” immune cells from human stem cells that reversed cognitive decline and Alzheimer’s ...

Scientists at the University of Cambridge have developed a new stem cell-based model that produces human blood cells in the ...

The same cell product could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...

"For the first time, we found that empagliflozin, an established diabetes and heart medication, reduced markers of brain ...

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...